Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00926146 · ClinicalTrials.gov registry record · NA
Hepatitis B Virus (HBV) Prevention for Homeless at Risk for HBV/Hepatitis C Virus (HCV)/HIV
A NA study, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- NA
- Development phase
- 451
- Enrollment target
NCT00926146 is a NA study that has completed, run by University of California, Los Angeles. The registered enrollment target is 451 participants.
The verdict
NCT00926146, a NA study, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- NA
- Development phase
- 451 participants
- Enrollment target
Study Summary
In this study, researchers from UCLA and Friends Community Center will work together in designing a program to assist young homeless stimulant-using gay and bisexual homeless men to complete the hepatitis vaccine and in reducing drug and sexual activity. Using nurse case management strategies, found successful with homeless adults as well as contingency management strategies, found successful with gay and bisexual homeless adults by the community partners, the investigators will evaluate the effectiveness of a program that combines both strategies. As stimulant use threatens to increase homeless persons' risk of exposure to hepatitis A and B viruses, particularly among young users who may not yet be HBV-infected, this research is targeted to engage this group in treatment, until they are suitably protected from HBV, and hopefully reduce risk for HCV and HIV as well.
Interventions
- BEHAVIORAL NCMIT
- BEHAVIORAL SCMIT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 451 participants |
| Start Date | 2009-07 |
| Est. Completion | 2015-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00926146
The ClinicalTrials.gov registry entry for NCT00926146 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 451 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which NCMIT is the first listed.
NCT00926146 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00926146 about?
NCT00926146 is a clinical study titled "Hepatitis B Virus (HBV) Prevention for Homeless at Risk for HBV/Hepatitis C Virus (HCV)/HIV". In this study, researchers from UCLA and Friends Community Center will work together in designing a program to assist young homeless stimulant-using gay and bisexual homeless men to complete the hepatitis vaccine and in reducing drug and sexual activity. Using nurse case management strategies, found...
What is the current status of trial NCT00926146?
This trial is currently completed. It is a NA study. The enrollment target is 451 participants. The study started on 2009-07. Estimated completion is 2015-02.
What interventions are being tested in trial NCT00926146?
The interventions under investigation include: NCMIT (BEHAVIORAL), SCMIT (BEHAVIORAL).
Who is sponsoring clinical trial NCT00926146?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.